What is the influence of cyclooxygenase-2 on postmenopausal endometrial polyps?

Climacteric

Volumn 18, Issue 4, 2015, Pages 498-502

  Pereira, A K C ^a   Garcia, M T ^a   Pinheiro, W ^a   Ejzenberg, D ^a   Soares, J M ^a   Baracat, E C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

COX 2; endometrial polyp; endometrium

Indexed keywords

CYCLOOXYGENASE 2; BIOLOGICAL MARKER; PTGS2 PROTEIN, HUMAN;

ENDOMETRIUM CANCER; ENDOMETRIUM POLYP; ENZYME ACTIVITY; FEMALE; HUMAN; MENSTRUAL CYCLE; PATIENT SELECTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; REVIEW; TUMOR GROWTH; ENDOMETRIUM; ENDOMETRIUM TUMOR; ENZYMOLOGY; METABOLISM; PATHOLOGY; POLYP; UTERUS DISEASE;

BIOMARKERS; CYCLOOXYGENASE 2; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; POLYPS; POSTMENOPAUSE; UTERINE DISEASES;

EID: 84932179095     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2014.966240     Document Type: Review

References (24)

1. Neto L C, Soares J M Jr, Giusa-Chiferi M G, Gon ç alves W J, Baracat EC. Expression of p53 protein in the endometrial polyp in postmenopausal women. Eur J Gynaecol Oncol 2013; 34: 509-12
2. Clevenger-Hoeeft M, Syrop CH, STtovall DW, et al. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol 1999; 94: 516-20
3. Cohen MA, Sauer MV, Keltz M, Lindheim R. Utilizing routine sonohysterography to detect intrauterine pathology before initiating hormone replacement therapy. Menopause 1999; 6: 68-70
4. Cakmak H, Taylor HS. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update 2011; 17: 242-53
5. Sant ' Ana de Almeida EC, Nogueira A A, Candido dos Reis F J, Zambelli Ramalo LN, Zucoloto S. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas 2004; 49: 229-33
6. Zitao Liu, Kuokkanen S, Pal L. Steroid hormone receptor profile of premenopausal endometrial polyps. Reprod Sci 2010; 17: 377-83
7. Antunes Jr. A, Vassallo J, Pinheiro A. Leã R, Neto A.M, Costa-Paiva L. Immunohistochemical expression of estrogen and pro-gesterone receptors in endometrial polyps: A comparison between benign and malignant polyps in postmenopausal patients Oncol Lett 2014 7 1944-1950.
8. Giordano G, Gnetti L, Merisio C, Melpignano M. P ostmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas 2007; 56: 190-7
9. Topcu HO, Erkaya S, Guzel AI et al. Risk factors for endometrial hyperplasia concomitant endometrial polyps in pre-and postmenopausal women. Asian Pac J Cancer Prev 2014; 15: 5423-5
10. Costa-Paiva L, Godoy CE Jr, Antunes A Jr, Caseiro JD, Arthuso M, Pinto-Neto AM. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause 2011; 18: 1278-82
11. Dreisler E, Rahimi S. T he oncogenic potential of endometrial polyps: A systematic review and meta-analysis. Obstet Gynecol 2011; 118: 361
12. Maia H Jr, Correia T, Freitas LA, Athayde C, Coutinho E. Cyclooxygenase-2 expression in endometrial polyps during menopause. Gynecol Endocrinol 2005; 21: 336-9
13. Maia H Jr, Pimentel K, Silva TM, Freitas LA, Zausner B, Athayde C, Coutinho EM. Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrinol 2006; 22: 219-24
14. Giordano G, Gnetti L, Merisio C, Melpignano M. P ostmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas 2007; 56: 190-7
15. Erdemoglu E, Gü ney M, Karahan N, Mungan T. E xpression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps. Maturitas 2008; 59: 268-74
16. Antunes A Jr, Andrade L A, Pinto G A, Le ão R, Pinto-Neto A M, Costa-Paiva L. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps? Anal Quant Cytol Histol 2012; 34: 264-72
17. Faloppa CC, Baiocchi G, Cunha IW, et al. NF-B and COX-2 expression in nonmalignant endometrial lesions and cancer. Am J Clin Pathol 2014; 141: 196-203
18. Pinheiro A, Antunes A Jr, Andrade L, De Brot L, Pinto-Neto A M, Costa-Paiva L. Expression of hormone receptors, Bcl-2, Cox-2 and Ki67 in benign endometrial polyps and their association with obesity. Mol Med Rep 2014; 9: 2335-41
19. O'Banion MK. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999; 13: 45-82
20. Carvalho F M, Aguiar F N, Tomioka R, d e Oliveira R M, Frantz N, Ueno J. Functional endometrial polyps in infertile asymptomatic patients: A possible evolution of vascular changes secondary to endometritis. Obstet Gynecol Reprod Biol 2013; 170: 152-6
21. Murakami M, Nakashima K, Kamei D, et a l. C ellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenasesa-1 and-2. J Biol Chem 2003; 278: 37937-47
22. Noble L S, Takayama K, Putman J M, et al. P rostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997; 82: 600-6
23. Brazowski E, Rozen P, Misonzhnick-Bedny F, Gitstein G. C haracteristics of familial juvenile polyps expressing cyclooxygenase-2. Am J Gastroenterol 2005; 100: 130-8
24. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491-505